No Data
No Data
No Data
No Data
No Data
Achilles Therapeutics Price Target Cut to $6.00/Share From $11.00 by Chardan Capital
Achilles Therapeutics Price Target Cut to $6.00/Share From $11.00 by Chardan Capital
Dow JonesApr 5 06:47 ET
Achilles Therapeutics Is Maintained at Buy by Chardan Capital
Achilles Therapeutics Is Maintained at Buy by Chardan Capital
Dow JonesApr 5 06:47 ET
Achilles Therapeutics Cut to Neutral From Overweight by Piper Sandler
Achilles Therapeutics Cut to Neutral From Overweight by Piper Sandler
Dow JonesApr 5 06:43 ET
Express News | Piper Sandler Downgrades Achilles Therapeutics to Neutral, Lowers Price Target to $2
Moomoo 24/7Apr 5 06:32 ET
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%
BenzingaApr 4 13:21 ET
BRNS, UPC and KWE Among Mid-day Movers
Seeking AlphaApr 4 13:06 ET
No Data
No Data